Sensan Biosciences Profile
Key Indicators
- Authorised Capital ₹ 99.00 K
- Paid Up Capital ₹ 50.00 K
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1298.24%
- Profit Growth -4448.46%
- Ebitda -3318.39%
- Net Worth -83.09%
- Total Assets -25.47%
About Sensan Biosciences
Sensan Biosciences Private Limited (SBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 01 May 2020 (Four years and nine months 14 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Sg Audit Nirvaaha Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 99.00 K and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Sankaranarayanan Premkumar and Durai Manikandan serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U72200TN2020PTC135258
-
Company No.
135258
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 May 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Sensan Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sankaranarayanan Premkumar
|
Additional Director | 29-Dec-2023 | Current |
| Durai Manikandan | Director | 06-Jan-2023 | Current |
Financial Performance of Sensan Biosciences.
Sensan Biosciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1298.24% increase. The company also saw a substantial fall in profitability, with a 4448.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 83.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sensan Biosciences?
In 2022, Sensan Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Symbiance Ai Private LimitedSankaranarayanan Premkumar is a mutual person
-
Sanvir Productions LlpSankaranarayanan Premkumar is a mutual person
-
Symbiance Academy Private Limited
Sankaranarayanan Premkumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sensan Biosciences?
Unlock and access historical data on people associated with Sensan Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sensan Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sensan Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
